Interfascial Dissection For Protection Of The Nerve Branches To The Frontalis Muscles During Supraorbital Trans-eyebrow Approach: An Anatomical Study And Technical Note

Preservation of the temporal branches of the facial nerve during anterolateral craniotomies is important. Damaging it can inflict undesirable cosmetic defects to the patient. The supraorbital trans-eyebrow approach (SOTE) is a versatile keyhole craniotomy but still has a high rate of frontalis muscle (FM) palsy. Objective Anatomical study to implement the interfascial dissection during the SOTE to preserve the nerves to the FM. Methods Slight modification of the standard technique of the SOTE was performed in 6 cadaveric specimens (12 sides). Results Distal rami to the FMwere exposed. The standard "U-shape" incision of the FM can cross over the nerves. Alternatively, an "L-shape" incision was performed until the superior temporal line (STL). An interfascial dissection was performed near to the STL and the interfascial fat pad was used as a protective layer for the nerves. Conclusion Various pathologies can be addressed with the SOTE. In the majority of the cases the cosmetic results are good, but FM palsy remains a drawback of this approach. The interfascial dissection may be used in an attempt to prevent frontalis rami palsy.77326527

Simulação em 3D da redução da fossa posterior no Chiari do tipo I

We proposed a 3D model to evaluate the role of platybasia and clivus length in the development of Chiari I (CI). Using a computer aided design software, two DICOM files of a normal CT scan and MR were used to simulate different clivus lengths (CL) and also different basal angles (BA). The final posterior fossa volume (PFV) was obtained for each variation and the percentage of the volumetric change was acquired with the same method. The initial normal values of CL and BA were 35.65 mm and 112.66 degrees respectively, with a total PFV of 209 ml. Ranging the CL from 34.65 to 29.65 - 24.65 - 19.65, there was a PFV decrease of 0.47% - 1.12% - 1.69%, respectively. Ranging the BA from 122.66 degrees to 127.66 degrees - 142.66 degrees, the PFV decreased 0.69% - 3.23%, respectively. Our model highlights the importance of the basal angle and clivus length to the development of CI.We proposed a 3D model to evaluate the role of platybasia and clivus length in the development of Chiari I (CI). Using a computer aided design software, two DICOM files of a normal CT scan and MR were used to simulate different clivus lengths (CL) and als745405408sem informaçãosem informaçãoNo presente estudo, propusemos a criação de um modelo computacional em 3D com elaboração de software onde dois arquivos em formato DICOM com uma TC e RNM de crânio foram usados para simular diferentes mensurações na extensão do clivus (EC) e no ângulo ba

Percutaneous Endoscopic Lumbar Approach to a Facet Joint Synovial Cyst: Case Report and Review of the Literature

Lumbar facet joint synovial cysts are rare lesions that may cause radiculopathy, usually it does not respond well to clinical management, oftentimes requiring surgical intervention. The percutaneous endoscopic approach may be an alternative that avoids the risk of instability. On this paper we describe the percutaneous endoscopic approach to a lumbar facet joint synovial cyst in a 78-years-old, female patient. 78-years-old female with a history of rheumatoid arthritis, which caused numerous deformities in peripheral joints. She was complaining of progressive neurogenic claudication and right-side sciatica for 6 months and a limited walking ability, the MRI revealed a 12 mm L4L5 right facet joint synovial cyst. The natural history of lumbar facet joint cysts is not completely understood. It has been linked in previous studies to degenerative spine diseases, such as spondylolistheses and scoliosis. There are rare publications or studies confirming the superiority of the endoscopic approach to these cysts due to its rarity. The percutaneous endoscopic approach may be an alternative. The percutaneous endoscopic approach to the lumbar. facet joins cysts is a viable approac

Há um período exato para cirurgia em pacientes com paraplegia secundária à compressão medular não traumática?

Paraplegia is a well-defined state of complete motor deficit in lower limbs, regardless of sensory involvement. The cause of paraplegia usually guides treatment, however, some controversies remain about the time and benefits for spinal cord decompression in nontraumatic paraplegic patients, especially after 48 hours of the onset of paraplegia. The objective of this study was to evaluate the benefits of spinal cord decompression in such patients. We describe three patients with paraplegia secondary to non-traumatic spinal cord compression without sensory deficits, and who were surgically treated after more than 48 hours of the onset of symptoms. All patients, even those with paraplegia during more than 48 hours, had benefits from spinal cord decompression like recovery of gait ability. The duration of paraplegia, which influences prognosis, is not a contra-indication for surgery. The preservation of sensitivity in this group of patients should be considered as a positive prognostic factor when surgery is taken into account.A paraplegia é uma condição de déficit motor completo dos membros inferiores, independente do envolvimento de sensibilidade. A causa da paraplegia normalmente guia o tratamento, porém existem controversas sobre o momento e o benefício da descompressão medular em pacientes paraplégicos, principalmente após 48 horas do início dessa condição. O objetivo deste trabalho foi avaliar o beneficio da descompressão medular nesses pacientes. Foram descritos três pacientes com paraplegia secundária à compressão medular não traumática, sem déficits sensoriais e que foram submetidos à cirurgia após 48 horas do início dessa condição. Todos os pacientes, inclusive aqueles com mais de 48 horas do início dos sintomas, apresentaram melhora neurológica com a descompressão medular, como a recuperação da habilidade de marcha. A duração da paraplegia, que influencia no prognóstico, não é uma contraindicação absoluta para o procedimento cirúrgico. A preservação de sensibilidade desse grupo de pacientes deve ser considerada como fator prognóstico positivo quando a cirurgia for levada em conta.50851

Transforaminal Percutaneous Endoscopic Lumbar Discectomy Through a Transfacet Approach: Detailed Surgical Technique

The percutaneous endoscopic lumbar discectomy (PELD) is a minimally invasive surgical approach described for the treatment of herniated lumbar disks. We aim to offer a brief anatomical review followed by a detailed and illustrated description of the transforaminal PELD technique using the Tom SHIDI endoscope and instrument set (MaxMoreSpine, Unterföhring, Germany).The transforaminal PELD through a transforaminal approach using Tom SHIDI allows safe surgical treatment of most lumbar hernias thanks to the posterior entrance into Kambin's Triangle through a bony landmark allowing foraminoplasty to be performed using a manual drill. Careful surgical technique minimizes unforeseen complications and makes this a safe and viable alternative to conventional microdiscectomy

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (n = 143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (n = 152), or no hydrocortisone (n = 108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (n = 137), shock-dependent (n = 146), and no (n = 101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707

Is There A Right Time For Surgery In Paraplegic Patients Secondary To Non Traumatic Spinal Cord Compression?

Paraplegia is a well-defined state of complete motor deficit in lower limbs, regardless of sensory involvement. The cause of paraplegia usually guides treatment, however, some controversies remain about the time and benefits for spinal cord decompression in nontraumatic paraplegic patients, especially after 48 hours of the onset of paraplegia. The objective of this study was to evaluate the benefits of spinal cord decompression in such patients. We describe three patients with paraplegia secondary to non-traumatic spinal cord compression without sensory deficits, and who were surgically treated after more than 48 hours of the onset of symptoms. All patients, even those with paraplegia during more than 48 hours, had benefits from spinal cord decompression like recovery of gait ability. The duration of paraplegia, which influences prognosis, is not a contra-indication for surgery. The preservation of sensitivity in this group of patients should be considered as a positive prognostic factor when surgery is taken into account.10508-1